Population pharmacokinetics of valganciclovir prophylaxis in paediatric and adult solid organ transplant recipients.
about
Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection.Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review.Plasma and intracellular exposure to ganciclovir in adult renal transplant recipients: is there an association with haematological toxicity?
P2860
Population pharmacokinetics of valganciclovir prophylaxis in paediatric and adult solid organ transplant recipients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Population pharmacokinetics of ...... d organ transplant recipients.
@ast
Population pharmacokinetics of ...... d organ transplant recipients.
@en
Population pharmacokinetics of ...... d organ transplant recipients.
@nl
type
label
Population pharmacokinetics of ...... d organ transplant recipients.
@ast
Population pharmacokinetics of ...... d organ transplant recipients.
@en
Population pharmacokinetics of ...... d organ transplant recipients.
@nl
prefLabel
Population pharmacokinetics of ...... d organ transplant recipients.
@ast
Population pharmacokinetics of ...... d organ transplant recipients.
@en
Population pharmacokinetics of ...... d organ transplant recipients.
@nl
P2093
P2860
P356
P1476
Population pharmacokinetics of ...... d organ transplant recipients.
@en
P2093
Heather E Vezina
Henry H Balfour
Richard C Brundage
P2860
P304
P356
10.1111/BCP.12343
P407
P577
2014-08-01T00:00:00Z